Sage Journals: Discover world-class research

Retricted access

Case report

First published 2018-9

Case Report of Empagliflozin-Induced Cutaneous Polyarteritis Nodosa

Derek To, Scott Bradshaw, Jennifer Lipson

Journal of Cutaneous Medicine and Surgery

Retricted access

Review article

First published 2015-5

Empagliflozin,an SGLT2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

John R. White

Annals of Pharmacotherapy

Free access

Research article

First published 2014-11

Nonclinical Safety of the Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin

Matthew S. Bogdanffy, Robert F. Stachlewitz, Susan van Tongeren [...]

International Journal of Toxicology

Free access

Review article

First published 2015-4

Short commentary on empagliflozin and its potential clinical impact

Deborah Hinnen

Therapeutic Advances in Endocrinology and Metabolism

Retricted access

Research article

First published 2020-10

Weight Outcomes With Empagliflozin as Compared With Liraglutide in Veterans With Type 2 Diabetes Mellitus

Ted Robert Grabarczyk, Natalie Koury Wissman

Annals of Pharmacotherapy

Open access

Review article

First published 2018

Combination of Empagliflozin and Metformin Therapy: A Consideration of its Place in Type 2 Diabetes Therapy

Jennifer D Goldman

Clinical Medicine Insights: Endocrinology and Diabetes

Open access

Research article

First published 2020-1

Effect of empagliflozin on brachial artery shear stress and endothelial function in subjects with type 2 diabetes: Results from an exploratory study

Concetta Irace, Antonio Cutruzzolà, Martina Parise [...]

Diabetes & Vascular Disease Research

Open access

Research article

First published 2021-5

Rationale and design of the randomised controlled cross-over trial: Cardiovascular effects of empaglifozin in diabetes mellitus

Sharmaine Thirunavukarasu, Louise AE Brown, Amrit Chowdhary [...]

Diabetes & Vascular Disease Research

Retricted access

Research article

First published 2024-10

Risk of Urinary Infections in Veterans on Empagliflozin With Concurrent Catheter Use

Rachel A. Hopper, Danni M. McMahan, Kathryn A. Jarvis [...]

Journal of Pharmacy Practice

Retricted access

Research article

First published 2026-1

Empagliflozin Attenuates Diabetic Cardiomyopathy via Inhibiting Cardiomyocyte Ferroptosis Through the USP7/NRF2 Signaling Pathway

Min Cui, Junwei Zhang, Ziwei Wang [...]

Antioxidants & Redox Signaling

Search results